Aspen Aerogels Hits 52-Week Low at $4.08 Amidst Significant Decline

Aspen Aerogels, Inc., a microcap company in the Other Industrial Products sector, has reached a new 52-week low of USD 4.08 on November 6, 2025. This significant decline marks a stark contrast to its 52-week high of USD 18.94, highlighting a challenging year for the company. Over the past year, Aspen Aerogels has experienced a dramatic performance drop of 86.89%, significantly underperforming the S&P 500, which has seen a gain of 17.53% during the same period.
Financial metrics reveal a P/E ratio of 13.00, indicating the company's valuation relative to its earnings. However, the company has faced difficulties, as evidenced by a return on equity of just 6.05% and a concerning operating profit decline of 58.5%. Additionally, Aspen Aerogels reported a pre-tax profit of USD -2.34 million, reflecting a 123.02% decrease, and a net profit of USD -3.16 million, down 132.73%. With a market capitalization of USD 557 million, the company is navigating a challenging landscape, marked by low profitability and significant underperformance compared to broader market trends.